CVE-2021-1617
Cisco Intersight Virtual Appliance Command Injection and Path Traversal Vulnerabilities
Description
Multiple vulnerabilities in the web-based management interface of Cisco Intersight Virtual Appliance could allow an authenticated, remote attacker to conduct a path traversal or command injection attack on an affected system. These vulnerabilities are due to insufficient input validation. An attacker could exploit these vulnerabilities by using the web-based management interface to do one or both of the following: Execute a command using crafted input Upload a file that has been altered using path traversal techniques A successful exploit could allow the attacker to read and write arbitrary files or execute arbitrary commands as root on an affected system. For more information about these vulnerabilities, see the Details section of this advisory.
INFO
Published Date :
July 22, 2021, 4:15 p.m.
Last Modified :
Nov. 7, 2023, 3:28 a.m.
Source :
[email protected]
Remotely Exploitable :
Yes !
Impact Score :
5.2
Exploitability Score :
1.2
References to Advisories, Solutions, and Tools
Here, you will find a curated list of external links that provide in-depth
information, practical solutions, and valuable tools related to
CVE-2021-1617.
| URL | Resource |
|---|---|
| https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-ucsi2-dtcinj-yH5U4RSx | Patch Vendor Advisory |
We scan GitHub repositories to detect new proof-of-concept exploits. Following list is a collection of public exploits and proof-of-concepts, which have been published on GitHub (sorted by the most recently updated).
Results are limited to the first 15 repositories due to potential performance issues.
The following list is the news that have been mention
CVE-2021-1617 vulnerability anywhere in the article.
The following table lists the changes that have been made to the
CVE-2021-1617 vulnerability over time.
Vulnerability history details can be useful for understanding the evolution of a vulnerability, and for identifying the most recent changes that may impact the vulnerability's severity, exploitability, or other characteristics.
-
CVE Modified by [email protected]
May. 14, 2024
Action Type Old Value New Value -
CVE Modified by [email protected]
Nov. 07, 2023
Action Type Old Value New Value Removed CVSS V3 Cisco Systems, Inc. AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:N Added CVSS V3.1 Cisco Systems, Inc. AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:N -
Reanalysis by [email protected]
Oct. 24, 2022
Action Type Old Value New Value Removed CWE NIST CWE-20 Added CWE NIST CWE-22 -
Reanalysis by [email protected]
Aug. 03, 2021
Action Type Old Value New Value Changed CPE Configuration OR *cpe:2.3:a:cisco:intersight_virtual_appliance:*:*:*:*:*:*:*:* versions up to (excluding) 1.0.9-292. OR *cpe:2.3:a:cisco:intersight_virtual_appliance:*:*:*:*:*:*:*:* versions up to (excluding) 1.0.9-292 -
Initial Analysis by [email protected]
Aug. 03, 2021
Action Type Old Value New Value Added CVSS V2 NIST (AV:N/AC:L/Au:S/C:P/I:P/A:N) Added CVSS V3.1 NIST AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:N Changed Reference Type https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-ucsi2-dtcinj-yH5U4RSx No Types Assigned https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-ucsi2-dtcinj-yH5U4RSx Patch, Vendor Advisory Added CWE NIST CWE-20 Added CPE Configuration OR *cpe:2.3:a:cisco:intersight_virtual_appliance:*:*:*:*:*:*:*:* versions up to (excluding) 1.0.9-292.
CWE - Common Weakness Enumeration
While CVE identifies
specific instances of vulnerabilities, CWE categorizes the common flaws or
weaknesses that can lead to vulnerabilities. CVE-2021-1617 is
associated with the following CWEs:
Common Attack Pattern Enumeration and Classification (CAPEC)
Common Attack Pattern Enumeration and Classification
(CAPEC)
stores attack patterns, which are descriptions of the common attributes and
approaches employed by adversaries to exploit the CVE-2021-1617
weaknesses.
Exploit Prediction
EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days.
0.09 }} 0.00%
score
0.35100
percentile